These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8466466

  • 21. Granulomatous pneumonitis following intravesical BCG. What therapy is needed?
    LeMense GP, Strange C.
    Chest; 1994 Nov; 106(5):1624-6. PubMed ID: 7956439
    [Abstract] [Full Text] [Related]

  • 22. [Tuberculous epididymitis caused by intravesical BCG therapy: a case report].
    Ishizu K, Hirata H, Yano S, Naito K, Furuya T, Muratani T, Kobayashi T.
    Hinyokika Kiyo; 2003 Sep; 49(9):539-42. PubMed ID: 14598693
    [Abstract] [Full Text] [Related]

  • 23. Epididymo-orchitis developing as a late manifestation of intravesical bacillus Calmette-Guerin therapy and masquerading as a primary testicular malignancy: a report of 2 cases.
    Truelson T, Wishnow KI, Johnson DE.
    J Urol; 1992 Nov; 148(5):1534-5. PubMed ID: 1433567
    [Abstract] [Full Text] [Related]

  • 24. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
    Rawls WH, Lamm DL, Lowe BA, Crawford ED, Sarosdy MF, Montie JE, Grossman HB, Scardino PT.
    J Urol; 1990 Dec; 144(6):1328-30. PubMed ID: 2231917
    [Abstract] [Full Text] [Related]

  • 25. Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinoma.
    Manfredi R, Dentale N, Piergentili B, Pultrone C, Brunocilla E.
    Cancer Biother Radiopharm; 2009 Oct; 24(5):621-7. PubMed ID: 19877893
    [Abstract] [Full Text] [Related]

  • 26. [Tuberculous epididymitis after Bacillus Calmette-Guérin intravesical therapy : a case report].
    Uno T, Numazaki S, Kato N, Egawa S.
    Hinyokika Kiyo; 2014 Jun; 60(6):291-4. PubMed ID: 25001646
    [Abstract] [Full Text] [Related]

  • 27. Mycobacterium bovis-BCG infection of the glans penis: a complication of intravesical administration of bacillus Calmette-Guerin.
    Ribera M, Bielsa J, Manterola JM, Fernández MT, Ferrándiz C.
    Br J Dermatol; 1995 Feb; 132(2):309-10. PubMed ID: 7888373
    [No Abstract] [Full Text] [Related]

  • 28. Reactive arthritis after the intravesical instillation of BCG.
    Macía Villa C, Sifuentes Giraldo W, Boteanu A, González Lanza M, Bachiller Corral J.
    Reumatol Clin; 2012 Feb; 8(5):284-6. PubMed ID: 22377450
    [Abstract] [Full Text] [Related]

  • 29. Pleural effusion after intravesical administration of bacillus Calmette-Guérin.
    Roca Noval A, Cisneros C, García-Pérez FJ, Domingo D.
    Arch Bronconeumol; 2017 Dec; 53(12):694-695. PubMed ID: 28476221
    [No Abstract] [Full Text] [Related]

  • 30. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration.
    Graziano DA, Jacobs D, Lozano RG, Buck RL.
    J Urol; 1991 Oct; 146(4):1118-9. PubMed ID: 1895437
    [Abstract] [Full Text] [Related]

  • 31. A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer.
    Lamm DL, DeHaven JI, Shriver J, Crispen R, Grau D, Sarosdy MF.
    J Urol; 1990 Jul; 144(1):65-7. PubMed ID: 2193172
    [Abstract] [Full Text] [Related]

  • 32. Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation.
    Hidoussi A, Slama A, Jaidane M, Zakhama W, Youssef A, Ben Sorba N, Mosbah AF.
    Urology; 2007 Sep; 70(3):591.e9-10. PubMed ID: 17905131
    [Abstract] [Full Text] [Related]

  • 33. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL, DeHaven JI, Shriver J, Sarosdy MF.
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [Abstract] [Full Text] [Related]

  • 34. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J, Stein B.
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [Abstract] [Full Text] [Related]

  • 35. The preparation, handling and use of intravesical bacillus Calmette-Guerin for the management of stage Ta, T1, carcinoma in situ and transitional cell cancer.
    Brosman SA, Lamm DL.
    J Urol; 1990 Aug; 144(2 Pt 1):313-5. PubMed ID: 2374197
    [Abstract] [Full Text] [Related]

  • 36. Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report.
    Hakim S, Heaney JA, Heinz T, Zwolak RW.
    J Urol; 1993 Jul; 150(1):188-9. PubMed ID: 8510250
    [Abstract] [Full Text] [Related]

  • 37. Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy.
    Pisters LL, Tykochinsky G, Wajsman Z.
    J Urol; 1991 Dec; 146(6):1514-7. PubMed ID: 1942330
    [Abstract] [Full Text] [Related]

  • 38. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.
    Witjes JA, vd Meijden AP, Debruyne FM.
    Urol Int; 1990 Dec; 45(3):129-36. PubMed ID: 2190404
    [Abstract] [Full Text] [Related]

  • 39. [Multiorgan failure following intravesical bacillus Calmette-Guerin administration: a case report].
    Baba Y, Ishizu K, Jojima K, Joko K, Nakamura K, Takihara H, Naito K.
    Hinyokika Kiyo; 1992 Sep; 38(9):1063-5. PubMed ID: 1414761
    [Abstract] [Full Text] [Related]

  • 40. The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.
    Bretton PR, Herr HW, Kimmel M, Whitmore WF, Laudone V, Oettgen HF, Fair WR.
    J Urol; 1990 Apr; 143(4):710-2; discussion 712-3. PubMed ID: 2313796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.